Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?

Neurology

Volumn 72, Issue 10, 2009, Pages 868-869

  Okun, Michael S ^a   Fernandez, Hubert H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DESIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; DATA ANALYSIS; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; EDITORIAL; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; FEMALE; MALE; MIDDLE AGED; NOTE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; CITALOPRAM; DEPRESSIVE DISORDER; DESIPRAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 64049096582     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000338145.24512.02     Document Type: Editorial

References (10)

1. Menza M, DeFronzo Dobkin R, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009;72:886-892.
2. Miller KM, Okun MS, Fernandez HF, Jacobson CET, Rodriguez RL, Bowers D. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord 2007;22:666-672.
3. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183-189. Quiz 313.
4. Devos D, Dujardin K, Poirot I, et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2008;23:850-857.
5. Papakostas GI. Tolerability of modern antidepressants. J Clin Psychiatry 2008;69suppl e1:8-13.
6. Sala M, Coppa F, Cappucciati C, et al. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs 2006;7: 256-263.
7. Avila A, Cardona X, Martin-Baranera M, Maho P, Sastre F, Bello J. Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 2003;23:509-513.
8. Chen P, Kales HC, Weintraub D, Blow FC, Jiang L, Mellow AM. Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample. J Geriatr Psychiatry Neurol 2007;20: 161-165.
9. Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G. Tolerability of paroxetine in Parkinson's disease: a prospective study. Mov Disord 2000;15:986-989.
10. Weintraub D, Taraborelli D, Morales KH, Duda JE, Katz IR, Stern MB. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study. J Neuropsychiatry Clin Neurosci 2006;18:377-383.